<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05021380</url>
  </required_header>
  <id_info>
    <org_study_id>PUMS</org_study_id>
    <nct_id>NCT05021380</nct_id>
  </id_info>
  <brief_title>Salivary Immune/Stress Biomarkers Among Children</brief_title>
  <acronym>OPI2</acronym>
  <official_title>Salivary Immune/Stress Biomarkers Among Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poznan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Paris 7 - Denis Diderot</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Poznan University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: The use of easily accessible biomarkers for assessing young patients' health is&#xD;
      important. This study's aim is a measuring stress/immune biomarkers in saliva of healthy&#xD;
      school-age children and compare subgroups according to age, sex, stress perception in dental&#xD;
      pain related to symptomatic irreversible pulpitis (SIP) and symptomatic apical periodontitis&#xD;
      (SAP).&#xD;
&#xD;
      Material and methods: 50 children diagnosed with SIP and SAP aged from 6 to 12 years old will&#xD;
      be treated with root canal treatment. Dental examination using DMF score and oral hygiene&#xD;
      level will be performedby experienced dentists. Salivary samples will be collected three&#xD;
      times: before treatment in day of first dental visit (1), after two weeks (2), and after next&#xD;
      two weeks = 30 days (3). Additionally, pain and stress perception will be examined by VAS&#xD;
      scale and questionnaires dedicated for children anxiety: Frankl behavior rating scale,&#xD;
      Venham's anxiety and behavior rating scale. Salivary immunoglobullins A, G, M, opiorphin,&#xD;
      free cortisol and amylase will be measured using commercially available ELISA kits. Results&#xD;
      will assess which of the measured salivary biomarkers is related to stress and dental pain,&#xD;
      suggesting its use for evaluating in non-invasive way in childhood.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Psychological stress impairs homeostasis in many aspects, including immune dysregulation with&#xD;
      important variability according to age and sex. Use of easily accessible biomarkers is of&#xD;
      importance to assess these changes in fragile subjects, as for example children, especially&#xD;
      in a context of exposure to childhood stress experience, when invasive sampling procedures&#xD;
      may increase the psychic stress.&#xD;
&#xD;
      Saliva is a promising tool which has been used both for acute and chronic stress Several&#xD;
      salivary immune biomarkers are now considered to be sensitive and reliable readouts of mental&#xD;
      stress in adult patients, among them free cortisol, alpha-amylase (sAA) and secretory&#xD;
      immunoglobulin IgA (sIgA), IgM, IgG and opiorphin (OPI).&#xD;
&#xD;
      These four biomarkers may be measured easily in saliva, but in variable amounts according to&#xD;
      age and sex, as well as in response to psychological stress. The main objective of this&#xD;
      exploratory study was therefore to compare salivary levels of opiorphin, cortisol, sAA, sIgA,&#xD;
      IgM, IgG in two groups of healthy children, 6-12 years old, a developmental age critical to&#xD;
      mental disorders and dental interventional treatment, with ELISA tests.&#xD;
&#xD;
      This study's aim is a measuring stress/immune biomarkers in saliva of healthy school-age&#xD;
      children and compare subgroups according to age, sex, stress perception in dental pain&#xD;
      related to symptomatic irreversible pulpitis (SIP) and symptomatic apical periodontitis&#xD;
      (SAP).&#xD;
&#xD;
      Material and methods: 50 children diagnosed with SIP and SAP aged from 6 to 12 years old will&#xD;
      be treated with root canal treatment. Dental examination using DMF score and oral hygiene&#xD;
      level will be performedby experienced dentists. Salivary samples will be collected three&#xD;
      times: before treatment in day of first dental visit (1), after two weeks (2), and after next&#xD;
      two weeks = 30 days (3). Additionally, pain and stress perception will be examined by VAS&#xD;
      scale and questionnaires dedicated for children anxiety: Frankl behavior rating scale,&#xD;
      Venham's anxiety and behavior rating scale. Salivary immunoglobullins A, G, M, opiorphin,&#xD;
      free cortisol and amylase will be measured using commercially available ELISA kits. Results&#xD;
      will assess which of the measured salivary biomarkers is related to stress and dental pain,&#xD;
      suggesting its use for evaluating in non-invasive way in childhood.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>4 Weeks</target_duration>
  <primary_outcome>
    <measure>dental pain</measure>
    <time_frame>30 days</time_frame>
    <description>Proportion of subjects showing no increase in dental pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>salivary biomarkers</measure>
    <time_frame>30 days</time_frame>
    <description>Proportion of subjects showing no increase in salivary biomarkers</description>
  </primary_outcome>
  <primary_outcome>
    <measure>dental anxiety</measure>
    <time_frame>30 days</time_frame>
    <description>Proportion of subjects showing no increase in stress perception</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Stress, Emotional</condition>
  <condition>Dental Anxiety</condition>
  <condition>Dental Pain and Sensation Disorder</condition>
  <condition>Cortisol; Hypersecretion</condition>
  <arm_group>
    <arm_group_label>Group</arm_group_label>
    <description>50 generally healthy children diagnosed with dental pain as symptomatic irreversible pulpitis (SIP) or symptomatic apical periodontitis (SAP) aged from 6 to 12 years old will be included to the GROUP.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>GROUP</intervention_name>
    <description>Non-invasive diagnosis of dental pain, dental root canal treatment, salivary specimen collection from the first visit to next and the last during 4 weeks of dental care</description>
    <arm_group_label>Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be recruited at University dental clinic in Child and Adolescent Section, one&#xD;
        experienced dentist will conduct all dental and salivary collection procedures.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  male or female&#xD;
&#xD;
          -  age 6 - 12 y.o.&#xD;
&#xD;
          -  complaint dental pain&#xD;
&#xD;
          -  diagnosis of symptomatic irreversible pulpitis or symptomatic apical periodontitis&#xD;
&#xD;
          -  assigned agreement to the informed consent form by parents/caregivers and children&#xD;
             cooperation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  use of analgesics or antibiotics prior 48 h before specimen collection&#xD;
&#xD;
          -  having a systemic disease&#xD;
&#xD;
          -  disorders interfering with salivary function or flow&#xD;
&#xD;
          -  regular medication intake interfering with salivary function or flow&#xD;
&#xD;
          -  having temporary infectious disease&#xD;
&#xD;
          -  having neurodevelopmental dysfunction (e.g ADHD)&#xD;
&#xD;
          -  lack of cooperation during dental visits&#xD;
&#xD;
          -  inability to understand the content of the informed consent form by parents/caregivers&#xD;
             and children&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elzbieta Paszynska, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Poznan University of Medical Sciences, Poland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yves Boucher, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Université de Paris &amp; Groupe Hospitalier Pitié Salpêtrière, 75006 Paris, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elzbieta Paszynska, Prof</last_name>
    <phone>48618547027</phone>
    <email>paszynska@ump.edu.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anna Krahel, DDS</last_name>
    <phone>48618547027</phone>
    <email>a.krahel@wp.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Poznan University of Medical Sciences</name>
      <address>
        <city>Poznań</city>
        <zip>60-812</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elzbieta Paszynska, Prof</last_name>
      <phone>+48618547027</phone>
      <email>paszynska@ump.edu.pl</email>
    </contact>
    <contact_backup>
      <last_name>Monika Dmitrzak-Weglarz, Prof</last_name>
      <phone>+48618547027</phone>
      <email>mweglarz@ump.edu.pl</email>
    </contact_backup>
    <investigator>
      <last_name>Anna Krahel, DDS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yves Boucher, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <reference>
    <citation>Paszynska E, Roszak M, Slopien A, Boucher Y, Dutkiewicz A, Tyszkiewicz-Nwafor M, Gawriolek M, Otulakowska-Skrzynska J, Rzatowski S, Dmitrzak-Weglarz M. Is there a link between stress and immune biomarkers and salivary opiorphin in patients with a restrictive-type of anorexia nervosa? World J Biol Psychiatry. 2020 Mar;21(3):220-229. doi: 10.1080/15622975.2019.1593502. Epub 2019 Apr 23.</citation>
    <PMID>30880537</PMID>
  </reference>
  <reference>
    <citation>Boucher Y, Braud A, Dufour E, Agbo-Godeau S, Baaroun V, Descroix V, Guinnepain MT, Ungeheuer MN, Ottone C, Rougeot C. Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study. Clin Oral Investig. 2017 Sep;21(7):2157-2164. doi: 10.1007/s00784-016-1991-0. Epub 2016 Nov 10.</citation>
    <PMID>27834029</PMID>
  </reference>
  <results_reference>
    <citation>Slavish DC, Szabo YZ. The effect of acute stress on salivary markers of inflammation: a systematic review protocol. Syst Rev. 2019 May 2;8(1):108. doi: 10.1186/s13643-019-1026-4.</citation>
    <PMID>31046830</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 19, 2021</study_first_submitted>
  <study_first_submitted_qc>August 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2021</study_first_posted>
  <last_update_submitted>August 19, 2021</last_update_submitted>
  <last_update_submitted_qc>August 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Poznan University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Elzbieta Paszynska</investigator_full_name>
    <investigator_title>Assoc. Prof.</investigator_title>
  </responsible_party>
  <keyword>saliva</keyword>
  <keyword>biomarkers</keyword>
  <keyword>cortisol</keyword>
  <keyword>IgA</keyword>
  <keyword>IgG</keyword>
  <keyword>IgM</keyword>
  <keyword>amylase</keyword>
  <keyword>opiorphin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sensation Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>we do not plan any individual participant data available share to other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

